Longevity Predictions
3 sourced future predictions currently published in the Longevity category. Every prediction rests on a source, a criterion and a probability.
- The First Efficacy Results From The TAME (Targeting Aging With Metformin) Trial Are Expected To Be Published Between 2027 And 2028, Providing The First Strong Signal On Whether Metformin Delays The First Onset Of Age-related Diseases In Non-diabetic Adults Aged 65-79. 2027
- Interim Results From The First Large Human Trials Testing Whether GLP-1 Drugs (Such As Semaglutide) Slow Aging Are Expected By 2031, Clarifying Whether These Drugs, Which Extended Mouse Lifespan By About 12 Percent, Affect Biological Aging Markers In Humans. 2031
- At Least One AI-discovered Drug Candidate Aimed At Extending Lifespan Is Expected To Enter Human Clinical Trials By 2034, With Tools Such As AlphaFold Compressing Drug Discovery Timelines From Years To Months. 2034